Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Nature Communications|June 8, 2018
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hubRocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Bone Marrow Transplantation|August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMTNoureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
The Lancet. Haematology|July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working PartyAli Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Bone Marrow Transplantation|August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeTobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.
Bone Marrow Transplantation|April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
Bone Marrow Transplantation|March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWPFrancesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Pageof 14